Editorial draft — not for publication yet. Alprazolam content needs clinical and legal review before publication. This is general information, not a legal decision about a product or action.
Quick answer
Some packages shown in official reporting say “Rlam-1 / Alprazolam Tablets I.P. 1mg”. This supports the narrow statement that certain packaging claims alprazolam. It does not establish that a specific tablet contains alprazolam, that the strength is accurate, or that products with the same name have consistent contents.
For general active-ingredient information, read the Alprazolam medicine guide.
The Rlam-1 label may claim alprazolam; that is not verification
A product name, tablet colour, shape, logo or imprint is not a chemical test. Do not rely on a web listing, photo-identification forum or seller statement to decide what an unregulated tablet contains.
HSE reported tramadol in specific Rlam-1 tablets
An HSE drug-trend update dated 17 December 2024 says Rlam-1 tablets known as “Red backs” had been found to contain tramadol, an opioid, rather than alprazolam as labelled. Tramadol has different effects and risks from alprazolam; opioid exposure can be especially dangerous when combined with alcohol, benzodiazepines or other depressants.
The alert is a warning about the identified tablets and broader uncertainty in the unregulated supply. It does not prove that every Rlam tablet contains tramadol, nor that another tablet labelled alprazolam is safe. Treat each unknown tablet as unknown.
What can testing and official records tell you?
A drug-checking result describes the sample that was tested. WEDINOS cautions that a result cannot be applied automatically to other samples or a wider batch. Even a reported match on one tablet cannot certify the next tablet from a visually similar pack.
The MHRA database and UK product leaflets help identify authorised products, but they do not identify a loose or unverified tablet. If you need to confirm a medicine dispensed to you, take the pack and dispensing label to a pharmacist; do not take a product until its identity is resolved.
Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.
Frequently asked questions
Is Rlam-1 definitely alprazolam?
No. A label is not proof of contents. HSE reported that specific Rlam-1 tablets contained tramadol instead of labelled alprazolam.
Does every Rlam-1 tablet contain tramadol?
The HSE alert does not establish that. It refers to specific reported tablets and warns that similar packets may contain different substances.
Can a photo or pill identifier confirm Rlam-1?
No. Appearance and online pill descriptions cannot reliably confirm the ingredients or strength of a particular tablet.
Sources and further reading
This draft draws on brand or manufacturer product information and UK sources below. Product information is market-specific; check the leaflet supplied with your exact product.
- Health Service Executive / Health Research Board event material: HSE drug-trend update: Rlam-1 tablets reported to contain tramadol
- Northern Ireland Organised Crime Task Force: Annual Report and Threat Assessment 2022–23 (Rlam-1 package photograph)
- WEDINOS, Public Health Wales: Sample results and limits on interpreting individual test results
- MHRA: Search the current UK medicines product database
Editorial status: Editorial draft — clinical, toxicology and regulatory review required before publication. Sources checked on 3 October 2026.
Related information
Read the Rlam-1 product overview or continue to another topic: